VGR Equips Doctors with UpToDate Clinical Decision Support from Wolters Kluwer
Wolters Kluwer Health announced today that Västra Götalandsregionen (VGR) is providing UpToDate Anywhere , the comprehensive, mobile-enabled clinical decision support (CDS) resource, to healthcare professionals at its nine regional hospitals.
This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180315005867/en/
VGR is responsible for healthcare and medical treatment for over half a million residents in Sweden’s second largest city, Gothenburg, and over a million residents in 48 other communities throughout the region’s 25,000 km2 . Now, with UpToDate Anywhere, VGR ensures access to the same high quality, evidence-based content across its nine regional general hospitals. This approach serves to reduce unnecessary, outdated or inappropriate treatments, while also ensuring care teams consider lower cost options that are as clinically effective as costly procedures.
Analysts at the market research firm Outsell, Inc. emphasize the significance of UpToDate for reducing variability of care in regions like VGR: “the respected clinical support tool is actually addressing a population health ‘meta-metric’: variability in the quality of healthcare. Access by municipal, regional, or national health ministries or agencies can directly impact and equalize care at a higher level, whether in a hospital, community clinic, or at home through a visiting nurse.”
Doctors and patients alike will benefit from UpToDate’s clinical faculty of more than 6,700 physician authors, editors, and peer-reviewers from more than 50 countries who apply their clinical expertise to critically evaluate and synthesize medical literature into clinical topics that can be quickly and easily accessed at the point of care.
“Partnering with VGR will make it possible for healthcare professionals to consistently and efficiently deliver the highest standards of care in the communities they serve, whether in Gothenburg or in smaller municipalities,” said Peter Bonis, MD, Chief Medical Officer, Clinical Effectiveness at Wolters Kluwer.
To learn more about UpToDate from Wolters Kluwer, please visit: http://www.uptodate.com .
To read the Outsell Insights
commentary, “It’s More Than an App:
UpToDate Anywhere Works toward Standardizing Quality of Care,” click
About Wolters Kluwer
Wolters Kluwer N.V. (AEX: WKL) is a global leader in information services and solutions for professionals in the health, tax and accounting, risk and compliance, finance and legal sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with specialized technology and services.
Wolters Kluwer Health is a leading global provider of information and point of care solutions for the healthcare industry. For more information about our products and the organization, visit http://www.wolterskluwer.com/ , follow @WKHealth or @Wolters_Kluwer on Twitter, like us on Facebook , follow us on LinkedIn , or follow WoltersKluwerComms on YouTube .
Wolters Kluwer | Clinical Effectiveness
André Rebelo, +1 781-392-2411
Public & Analyst Relations Manager, UpToDate
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra Business Wire
NY-YOOZOO-GAMES26.3.2019 00:02:12 CET | Pressemeddelelse
Game of Thrones Winter is Coming™ Launches Worldwide
MD-EARTH-NETWORKS26.3.2019 00:02:12 CET | Pressemeddelelse
Earth Networks Announces Completion of Severe Weather Early Warning System for PAGASA
MA-BLUEBIRD-BIO25.3.2019 23:42:10 CET | Pressemeddelelse
bluebird bio Statement on European Regulatory Status of LentiGlobin™
NJ-CELGENE25.3.2019 21:32:03 CET | Pressemeddelelse
Celgene Submits Application to FDA for Ozanimod for the Treatment of Relapsing Forms of Multiple Sclerosis
UK-THALASSAEMIA-SOCIETY25.3.2019 20:52:11 CET | Pressemeddelelse
AVLT and UKTS Announce the European Medicines Agency’s Approval of the Conditional Marketing Authorization Application for Zynteglo™ (Previously Known as Lentiglobin™) Gene Therapy for the Treatment of Transfusion Dependent Beta Thalassaemia
INSTITUT-CURIE25.3.2019 17:56:11 CET | Pressemeddelelse
Historic Partnership between the Weizmann Institute of Science and Institut Curie
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.Besøg vores nyhedsrum